No third party authorised to supply Sputnik V vaccine, says Dr. Reddy’s Laboratories

Reiterating that it has the only distribution rights of the primary 250 million doses of the Russian Sputnik V vaccine in India, Dr. Reddy’s Laboratories on Friday stated it has not authorised any third party or middleman to supply the vaccine on its behalf within the nation.

Nor has it entered into any partnership or collaboration with any party to supply the vaccine to residential associations, the pharma main stated in a joint assertion with the Russian Direct Investment Fund (RDIF).

Noting that Dr. Reddy’s is the model custodian of Sputnik V vaccine within the nation and has the only distribution rights of the primary 250 million doses (first and second dose parts included), the assertion stated, “Beware of unauthorised individuals offering fake deals or procurement of the Sputnik V vaccine posing as its representatives in India. If approached, alert the authorities immediately.”

In the previous few days, there have been a number of unsubstantiated reviews and claims from numerous quarters in India on alleged tie-ups for the Sputnik V vaccine. The assertion stated Dr. Reddy’s has initiated authorized motion in opposition to unscrupulous components committing fraud within the title of the Sputnik V vaccine in India including that it takes no duty for the results of unauthorised offers, fraudulent monetary transactions or sub-standard merchandise ensuing from such fraud.

The drugmaker, with whom RDIF had entered right into a partnership on Sputnik V final yr, stated it has in place chilly storage logistics in addition to track-and-trace preparations for the vaccine. Ahead of the industrial launch of the vaccine in mid-June, Dr. Reddy’s continues to have interaction in direct talks with the federal government and the non-public sector to discover partnerships, the assertion stated.